These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1954351)

  • 1. In vitro growth pattern of myeloma cells in liquid suspension or semi-solid culture containing interleukin-6.
    Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Okada T; Okada H; Imura H
    Int J Hematol; 1991 Feb; 54(1):41-7. PubMed ID: 1954351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
    Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
    Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth.
    Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Fukumoto M; Okada T; Okada H; Imura H
    Leukemia; 1991 Jul; 5(7):585-91. PubMed ID: 2072743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
    Bataille R; Klein B
    Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
    Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
    Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of multiple myeloma cell growth].
    Simizu S; Konda S
    Rinsho Ketsueki; 1993 Apr; 34(4):418-22. PubMed ID: 8510327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
    Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
    J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
    Jourdan M; Tarte K; Legouffe E; Brochier J; Rossi JF; Klein B
    Eur Cytokine Netw; 1999 Mar; 10(1):65-70. PubMed ID: 10210775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
    Keller ET; Ershler WB
    J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
    Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 autocrine growth system in human multiple myeloma.
    Nagata K; Tanaka Y; Oda S; Yamashita U; Eto S
    Jpn J Clin Oncol; 1991 Feb; 21(1):22-9. PubMed ID: 2067118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
    Jourdan M; De Vos J; Mechti N; Klein B
    Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
    Takahashi T; Okuno Y; Ohsugi Y
    Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.
    Billadeau D; Jelinek DF; Shah N; LeBien TW; Van Ness B
    Cancer Res; 1995 Aug; 55(16):3640-6. PubMed ID: 7627974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon beta 2/interleukin-6 and interleukin-3 synergize in stimulating proliferation of human early hematopoietic progenitor cells.
    Michalevicz R; Lifshitz D; Revel M
    Scanning Microsc; 1989 Dec; 3(4):1143-9; discussion 1149-50. PubMed ID: 2633333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.